Home › Leukemia › Tennessee › Nashville

Pag-aaral pangklinika para sa Leukemia sa Nashville, TN

Isang pag-aaral para sa Leukemia ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Nashville. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

Nagre-recruitPhase 3

Quetzal Site 12, Nashville

Edad 18 hanggang 71 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07504458

Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies

Nagre-recruitPhase 1/2

Sarah Cannon Research Institute, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07284433

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Nagre-recruitPhase 3

Tennessee Oncology, Nashville
TriStar Centennial Medical Center, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT07007312

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Nagre-recruitPhase 1

Vanderbilt University Medical Center, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT06001788

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Nagre-recruitPhase 1/2

TriStar BMT, Nashville

Edad 13 hanggang 90 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT06533579

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Nagre-recruitPhase 2

Vanderbilt University, Ingram Cancer Center, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 7, 2026 · NCT07216443

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Nagre-recruitPhase 2/3

Vanderbilt University Medical Center, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 30, 2026 · NCT04256317

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Nagre-recruitPhase 1

TriStar Bone Marrow Transplant, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 13, 2026 · NCT05735184

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Vanderbilt-Ingram Cancer Center, Nashville

Edad 40 pataas · Lahat ng kasarian · Na-update Ene 20, 2026 · NCT05366881

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Nashville

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

Nagre-recruitPhase 1

Sarah Cannon Research Institute, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2025 · NCT06501196

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

Nagre-recruitPhase 1

TriStar Bone Marrow Transplant, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 15, 2024 · NCT06034275

Pag-aaral para sa Leukemia sa ibang lungsod

Iba pang pag-aaral sa Nashville

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.